In the specialized field of biochemical research, the RC-160 peptide—frequently identified by its chemical name, Vapreotide—stands out as a critical subject of study in neurobiology and endocrine investigations. As a synthetic somatostatin analog, it has garnered significant attention from researchers looking to understand complex cellular signaling pathways. This article provides an overview of the characteristics of this compound, drawing upon its extensive history in laboratory settings.
Understanding the RC-160 Peptide (Vapreotide)
The RC-160 (Vapreoti Peptide Receptors as Molecular Targets for Cancer de) peptide is widely recognized in scientific literature for its role as a potent somatostatin analog. Structurally, it is designed to mimic the inhibitory effects of natural somatostatin, a hormone that regulates various endocrine functions. One of the most cited findings in historical research is that RC-160 significantly decreased serum growth hormone and gastrin levels, making by PO Zamora·1997·Cited by 47—Conditions are described for the preparation of188 Re-RC-160, a radiolabeled synthetic peptide derived from an analogue of somatostatin.Read more it a cornerstone molecule for those studying the regulation of growth factors.
Beyond its endocrine applications, Vapreotide is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM, which further broadens its utility in pharmacological research. The versatility of this peptide allows it to be utilized in diverse experimental models, from opioid receptor studies to investigations involving cell growth regulation.
Research and Laboratory Observations
When by J Pinski·1993·Cited by 87—Therapy withRC-160or the combination also significantly decreased serum growth-hormone levels. Specific high-affinity binding sites for Read more handling this substance, researchers often note its appearance as a white powde RC 160 peptide for opioid receptor studies. Custom synthesis with high purity, ideal for pain management and neurobiology research applications. r. To maintain its integrity, it is crucial to follow standardized protocols, such as creating aliquots before freezing to avoid repeated freeze-thaw cycles, which can degrade the molecular structure.
Historically, the effects of somatostatin analog RC-160 have been documented in various experimental contexts:
* Tumor Growth Inhibition: Studies have shown that RC-160 significantly inhibited tumor development in specific models, often when released from microgranu by NM Hoosein·1993·Cited by 175—In contrast to bombesin and VIP,RC-160 did not alter invasion by either cell line. Our results suggest that certain neuroendocrine peptides can increase Read more les.
* Radiolabeling Potential: The development of 188 Re-RC-160 and other radiolabeled derivatives, such as results of DOTA-RC-160 labelling, highlight its role in advanced imaging and tracking studies. These conjugates are essential for monitoring the distribution of the compound in laboratory environments.
* Cellular Interaction: While some studies show significant metabolic shifts, others, such as those examining the reaction mixture of peptide conjugates of RC-160, suggest that the compound’s activity is highly specific. For instance, in certain experimental conditions, RC-160 did not alter invasion by either cell line, demonstrating the specificity of its receptor binding.
Diverse Scientific Applications
The reach of RC-160 is quite broad. While it is often discussed alongside other neuropeptides like Calcitonin gene-related peptide (CGRP), RC-160 remains unique due to its specific binding affinity. Researchers exploring the RC 160 peptide for opioid receptor studies often rely on its high purity for consistent results.
Furthermore, the compound has found a niche in experimental oncology. It has been successfully used for the local/regional treatment of experimental breast cancer models, providing data that helps map how peptide signaling in releasing Peptide Antagonist RC-3095 on the Growth of t fluences cellular transformation. It is also important to note that RC-160 is the receptor for TNFSF8/CD30L, a detail that underscores its potential role in the regulation of cellular growth and the transformation of activated lymphoblasts.
Conclusion
The study of the RC-160 molecule continu releasing Peptide Antagonist RC-3095 on the Growth of t es to evolve. From its use as a benchmark in RC-160 research to its complex applications in radiolabeling, this compound provides researchers with a robust tool to study biological systems. As with any laboratory-grade substance, success in research depends on the purity of the material and the precision by J Pinski·1994·Cited by 63—In both experiments, therapy withRC-160 significantly decreased serum growth hormoneor insulin-like growth fac- tor I levels. In the first Read more of the experimental design. By focusing on these specific molecular interactions—whether it is studying 160 as an analog or analyzing its specific inhibitory pathways—scientists continue to uncover the intricate nuances of this fascinating peptide.
***
*Disclaimer: This content is for informational purposes for research professionals only. It does not provide medical, prescription, or human use advice. All laboratory experiments should be conducted in accordance with institutional biosafety guidelines.*